Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 132.28M
June 30, 2026 74.21M
March 31, 2026 54.54M
December 31, 2025 -68.98M
September 30, 2025 -86.38M
June 30, 2025 -48.20M
March 31, 2025 -8.679M
December 31, 2024 33.29M
September 30, 2024 -138.38M
June 30, 2024 -207.00M
March 31, 2024 -198.54M
December 31, 2023 -145.25M
Date Value
September 30, 2023 -183.09M
June 30, 2023 -62.67M
March 31, 2023 -154.83M
December 31, 2022 -290.82M
September 30, 2022 -75.56M
June 30, 2022 -222.28M
March 31, 2022 -247.28M
December 31, 2021 -283.05M
September 30, 2021 -262.60M
June 30, 2021 -252.10M
March 31, 2021 -174.74M
December 31, 2020 -119.19M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Humana, Inc. 3.139B
Centene Corp. 3.943B
CVS Health Corp. 15.57B
UnitedHealth Group, Inc. 22.83B
Elevance Health, Inc. 6.514B